Habitual coffee consumption inversely associated with metabolic syndrome-related biomarkers involving adiponectin

Nutrition

Volumn 29, Issue 7-8, 2013, Pages 982-987

  Mure, Kanae ^a   Maeda, Shinya ^a,b   Mukoubayashi, Chizu ^b   Mugitani, Kouichi ^b   Iwane, Masataka ^b   Kinoshita, Fujihisa ^b   Mohara, Osamu ^b   Takeshita, Tatsuya ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Wakayama Wellness Foundation   (Japan)

Author keywords

Adiponectin; Coffee; Metabolic syndrome; Subcutaneous fat area; Visceral fat area

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; COFFEE; CROSS-SECTIONAL STUDY; FOOD INTAKE; HUMAN; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SUBCUTANEOUS FAT;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL; COFFEE; CROSS-SECTIONAL STUDIES; FOOD HABITS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOLECULAR WEIGHT; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS; SUBCUTANEOUS FAT;

EID: 84878957895     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.01.011     Document Type: Article

References (50)

1. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
2. Grundy S.M. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28:629-636.
3. Outline for the results of the National Health and Nutrition Survey Japan, 2006 2006, Health-Service-Bureau, Ministry of Health, Labour and Welfare, Japan.
4. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004, 109:42-46.
5. McNeill A.M., Rosamond W.D., Girman C.J., Golden S.H., Schmidt M.I., East H.E., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005, 28:385-390.
6. Pais R., Silaghi H., Silaghi A.C., Rusu M.L., Dumitrascu D.L. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 2009, 15:5141-5148.
7. Osaki Y., Taniguchi S., Tahara A., Okamoto M., Kishimoto T. Metabolic syndrome and incidence of liver and breast cancers in Japan. Cancer Epidemiol 2012, 36:141-147.
8. Sirtori C.R., Galli C., Anderson J.W., Sirtori E., Arnoldi A. Functional foods for dyslipidaemia and cardiovascular risk prevention. Nutr Res Rev 2009, 22:244-261.
9. Esposito K., Maiorino M.I., Ceriello A., Giugliano D. Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review. Diabetes Res Clin Pract 2010, 89:97-102.
10. Fappa E., Yannakoulia M., Pitsavos C., Skoumas I., Valourdou S., Stefanadis C. Lifestyle intervention in the management of metabolic syndrome: could we improve adherence issues?. Nutrition 2008, 24:286-291.
11. Wu J.N., Ho S.C., Zhou C., Ling W.H., Chen W.Q., Wang C.L., et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol 2009, 137:216-225.
12. Arab L. Epidemiologic evidence on coffee and cancer. Nutr Cancer 2010, 62:271-283.
13. van Dam R.M., Hu F.B. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005, 294:97-104.
14. Freedman N.D., Park Y., Abnet C.C., Hollenbeck A.R., Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012, 366:1891-1904.
15. Hino A., Adachi H., Enomoto M., Furuki K., Shigetoh Y., Ohtsuka M., et al. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract 2007, 76:383-389.
16. Driessen M.T., Koppes L.L., Veldhuis L., Samoocha D., Twisk J.W. Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Nutr 2009, 63:536-542.
17. Matsuura H., Mure K., Nishio N., Kitano N., Nagai N., Takeshita T. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol 2012, 22:160-166.
18. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
19. Standards of medical care in diabetes-2011. Diabetes Care 2011, 34(suppl 1):S11-S61. American Diabetes Association.
20. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010, 314:1-16.
21. Williams C.J., Fargnoli J.L., Hwang J.J., van Dam R.M., Blackburn G.L., Hu F.B., et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 2008, 31:504-507.
22. Kashiwagi A., Kasuga M., Araki E., Oka Y., Hanafusa T., Ito H., et al. International clinical harmonization of glycated hemoblobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig 2012, 3:39-40.
23. de Koning Gans J.M., Uiterwaal C.S., van der Schouw Y.T., Boer J.M., Grobbee D.E., Verschuren W.M., et al. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol 2010, 30:1665-1671.
24. Sartorelli D.S., Fagherazzi G., Balkau B., Touillaud M.S., Boutron-Ruault M.C., de Lauzon-Guillain B., et al. Differential effects of coffee on the risk of type 2 diabetes according to meal consumption in a French cohort of women: the E3N/EPIC cohort study. Am J Clin Nutr 2010, 91:1002-1012.
25. Hayashi T., Boyko E.J., McNeely M.J., Leonetti D.L., Kahn S.E., Fujimoto W.Y. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 2008, 57:1269-1275.
26. Fox C.S., Massaro J.M., Hoffmann U., Pou K.M., Maurovich-Horvat P., Liu C.Y., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
27. Hanhineva K., Torronen R., Bondia-Pons I., Pekkinen J., Kolehmainen M., Mykkanen H., et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010, 11:1365-1402.
28. Belza A., Toubro S., Astrup A. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. Eur J Clin Nutr 2009, 63:57-64.
29. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B. Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006, 8:264-280.
30. Matsuzawa Y. Therapy Insight: adipocytokines in metabolic syndrome andrelated cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006, 3:35-42.
31. Imatoh T., Tanihara S., Miyazaki M., Momose Y., Uryu Y., Une H. Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males. Eur J Nutr 2011, 50:279-284.
32. Kempf K., Herder C., Erlund I., Kolb H., Martin S., Carstensen M., et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 2010, 91:950-957.
33. Yamashita K., Yatsuya H., Muramatsu T., Toyoshima H., Murohara T., Tamakoshi K. Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutrition & diabetes 2012, 2:e33.
34. Bobbert T., Rochlitz H., Wegewitz U., Akpulat S., Mai K., Weickert M.O., et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 2005, 54:2712-2719.
35. Aso Y., Yamamoto R., Wakabayashi S., Uchida T., Takayanagi K., Takebayashi K., et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006, 55:1954-1960.
36. Hoelzl C., Knasmuller S., Wagner K.H., Elbling L., Huber W., Kager N., et al. Instant coffee with high chlorogenic acid levels protects humans against oxidative damage of macromolecules. Mol Nutr Food Res 2010, 54:1722-1733.
37. Misik M., Hoelzl C., Wagner K.H., Cavin C., Moser B., Kundi M., et al. Impact of paper filtered coffee on oxidative DNA-damage: results of a clinical trial. Mutat Res 2010, 692:42-48.
38. Gletsu-Miller N., Hansen J.M., Jones D.P., Go Y.M., Torres W.E., Ziegler T.R., et al. Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery. Obesity (Silver Spring) 2009, 17:439-446.
39. Van der Zwan L.P., Scheffer P.G., Dekker J.M., Stehouwer C.D., Heine R.J., Teerlink T. Hyperglycemia and oxidative stress strengthen the association between myeloperoxidase and blood pressure. Hypertension 2010, 55:1366-1372.
40. Vincent H.K., Taylor A.G. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006, 30:400-418.
41. Lamb R.E., Goldstein B.J. Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function. Int J Clin Pract 2008, 62:1087-1095.
42. Shen L. Beneficial effects of coffee consumption go beyond antioxidation. Nutrition 2012, 28:1194-1195.
43. Shen T., Park Y.C., Kim S.H., Lee J., Cho J.Y. Nuclear factor-kappaB/signal transducers and activators of transcription-1-mediated inflammatory responses in lipopolysaccharide-activated macrophages are a major inhibitory target of kahweol, a coffee diterpene. Biol Pharm Bull 2010, 33:1159-1164.
44. Kalthoff S., Ehmer U., Freiberg N., Manns M.P., Strassburg C.P. Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach. Gastroenterology 2010, 139:1699-1710. 710 e1-2.
45. Zhang Y., Lee E.T., Cowan L.D., Fabsitz R.R., Howard B.V. Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: The Strong Heart Study. Nutr Metab Cardiovasc Dis 2011, 21:418-423.
46. Rebello S.A., Chen C.H., Naidoo N., Xu W., Lee J., Chia K.S., et al. Coffee and tea consumption in relation to inflammation and basal glucose metabolism in a multi-ethnic Asian population: a cross-sectional study. Nutrition 2011, 10:61.
47. Geleijnse J.M. Habitual coffee consumption and blood pressure: an epidemiological perspective. Vasc Health Risk Manag 2008, 4:963-970.
48. Zhang Z., Hu G., Caballero B., Appel L., Chen L. Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. Am J Clin Nutr 2011, 93:1212-1219.
49. Kotani K., Fujiwara S., Hamada T., Tsuzaki K., Sakane N. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: response to Williams etal. Diabetes Care 2008, 31:e46. author reply e7.
50. Marques-Vidal P., Bochud M., Paccaud F., Mooser V., Waeber G., Vollenweider P. Distribution of plasma levels of adiponectin and leptin in an adult Caucasian population. Clin Endocrinol 2010, 72:38-46.